Asia Pacific Diagnostic Imaging Market – Industry Analysis and Market Forecast (2019-2027) _ by Products, Applications, End-User, and Geography


Asia Pacific Diagnostic Imaging Market is expected to grow at a CAGR of 5.98% during the forecast period. Asia Pacific Diagnostic Imaging Market is expected to reach US$ 8.99 Bn. by 2027.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.



To know about the Research Methodology:-Request Free Sample Report

Medical imaging refers to the various technologies that are being used to view the human body for diagnosis, monitoring, or treating different medical conditions. Every type of technology being used gives a different information about the area of the body being studied or treated. This is in relation to the possible disease, injury, or the effectiveness of medical treatment. The diagnostic imaging techniques use high-energy modalities such as magnetic resonance, tomography, X-rays, and ultrasound among others to allow visualization of body tissues.

The application of diagnostic imaging has increased dramatically over the past decade, together contributing to the medical costs as well as to the medical exposure towards ionizing radiation. Different factors have contributed to the upsurge in market demand, including wider availability of technology, favorable reimbursement, and increased demand by both patients as well as physicians. One potential harm related to the increased usage of CT use, which forms a significant segment for the overall diagnostic imaging market, bears special mention due to its importance in the health care quality.

Although CT is normally considered as one of the most important technological advancements in medicine, yet the substantial radiation exposure remains a challenge for its wide-spread applications. Radiation is of concern as extensive epidemiologic evidence has been linked to the subsequent development of cancer, thus forming a major restraint for the market growth. certain key trends being observed include hybrid imaging technology, imaging systems with lowered doses of ionizing radiation, contrast agents in diagnostic imaging, and cryogen-free preclinical MRI scanners. Furthermore, the development of cryogen-free preclinical MRI scanners along with automated CT scanners are high in demand and will likely provide new opportunities for the market growth of diagnostic imaging market.

The Asia Pacific is one of the major markets for diagnostic imaging globally where China, Japan, and India among others are some of the major regions contributing to the overall growth. The Asia Pacific region have substantiated itself globally in the area of healthcare through medical research activities. Advancements being made in the healthcare infrastructure have made way for timely diagnosis and making scanners available across all the regions. There has been an added support from the government through medical grants and policies that have together resulted in the growth of the diagnostic imaging market in Asia Pacific region.

Asia Pacific Diagnostic Imaging Market, Key Highlights:

• Asia Pacific Diagnostic Imaging market size analysis and forecast
• Comprehensive study and analysis of market drivers, restraints, and opportunities influencing growth of the Asia Pacific Diagnostic Imaging market
• Asia Pacific Diagnostic Imaging Market segmentation on the basis of applications, products, end-user, and geography
• Asia Pacific Diagnostic Imaging Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study
• Asia Pacific Diagnostic Imaging Market analysis and forecast for major countries has been provided.
• Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies
• Competitive landscape of the key players operating in the Asia Pacific Diagnostic Imaging Market including competitive developments, investments, and strategic expansion.

Key players of the Asia Pacific Diagnostic Imaging market:

 Fujifilm Holdings
 Shimadzu Corporation
 Carestream Health
 Toshiba Medical Systems Corporation
 Hitachi Medical Corporation
 Safwan
 SCETI K.K.
 Yasu Medical Imaging Technology Co., Ltd
 GE Healthcare
 Philips Healthcare
 Siemens Healthcare
 Medtech
 TEAC
 Ambra Health
 Bracco Imaging S.p.A.
 Voyager Imaging
 Integral Diagnostics
 Alpenglow Australia
 Barwon Medical Imaging
 Medirays Corporation

The Scope of the Asia Pacific Diagnostic Imaging Market: Inquire before buying

The research report segments Asia Pacific Diagnostic Imaging market based on application, product, end-user, and geography.

Asia Pacific Diagnostic Imaging Market, by Application:

• OB/GYN
• MSK
• Cardiology
• Oncology

Asia Pacific Diagnostic Imaging Market, by Products:

• X-ray Imaging
• Digital
• Analog
• MRI
• Closed
• Open
• Ultrasound
• CT
• Nuclear Imaging
• SPECT
• Hybrid PET

Asia Pacific Diagnostic Imaging Market, by End-User:

• Hospitals
• Imaging centres

Asia Pacific Diagnostic Imaging Market, By Geography:

• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia

Asia Pacific Diagnostic Imaging Market, Geographic Analysis

• Breakdown of China Diagnostic Imaging market
• Breakdown of Japan Diagnostic Imaging market
• Breakdown of India Diagnostic Imaging market
• Breakdown of South Korea Diagnostic Imaging market
• Breakdown of Australia Diagnostic Imaging market

Available Customization

Maximize Market Research offers customizations of reports according to the specific requirement of our clients. 





Asia Pacific Diagnostic Imaging Market

1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY
2.1. Market Definition
2.2. Market Scope
2.3. Data Sources

3. MARKET VARIABLES SCOPE
3.1. Market Segmentation Scope
3.2. Market Driver Analysis
3.3. Market Restraint Analysis
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis

4. ASIA PACIFIC DIAGNOSTIC IMAGING PRODUCT ESTIMATES TREND ANALYSIS (2019 – 2026)
4.1. Diagnostic Imaging Market: Product Analysis
4.2. X-ray Imaging
4.2.1. X-ray Imaging market, 2019 – 2026 (USD Billion)
4.3. Digital
4.3.1. Digital market, 2019 – 2026 (USD Billion)
4.4. Analog
4.4.1. Analog market, 2019 – 2026 (USD Billion)
4.5. MRI
4.5.1. MRI market, 2019 – 2026 (USD Billion)
4.6. Closed
4.6.1. Closed market, 2019 – 2026 (USD Billion)
4.7. Open
4.7.1. Open market, 2019 – 2026 (USD Billion)
4.8. Ultrasound
4.8.1. Ultrasound market, 2019 – 2026 (USD Billion)
4.9. CT
4.9.1. CT market, 2019 – 2026 (USD Billion)
4.10. Nuclear Imaging
4.10.1. Nuclear Imaging market, 2019 – 2026 (USD Billion)
4.11. SPECT Diagnostic Imaging
4.11.1. SPECT Diagnostic Imaging market, 2019 – 2026 (USD Billion)
4.12. Hybrid PET Diagnostic Imaging
4.12.1. Hybrid PET Diagnostic Imaging market, 2019 – 2026 (USD Billion)

5. ASIA PACIFIC DIAGNOSTIC IMAGING APPLICATION ESTIMATES TREND ANALYSIS (2019 – 2026)
5.1. Diagnostic Imaging Market: Application Analysis
5.2. OB/GYN Diagnostic Imaging
5.2.1. OB/GYN Diagnostic Imaging market, 2019 – 2026 (USD Billion)
5.3. MSK Diagnostic Imaging
5.3.1. MSK Diagnostic Imaging market, 2019 – 2026 (USD Billion)
5.4. Cardiology Diagnostic Imaging
5.4.1. Cardiology Diagnostic Imaging market, 2019 – 2026 (USD Billion)
5.5. Oncology Diagnostic Imaging
5.5.1. Oncology Diagnostic Imaging market, 2019 – 2026 (USD Billion)

6. ASIA PACIFIC DIAGNOSTIC IMAGING END-USER ESTIMATES TREND ANALYSIS (2019 – 2026)
6.1. Diagnostic Imaging Market: End-User Analysis
6.2. Hospitals
6.2.1. Hospitals market, 2019 – 2026 (USD Billion)
6.3. Imaging centers
6.3.1. Imaging centers market, 2019 – 2026 (USD Billion)

7. REGIONAL DIAGNOSTIC IMAGING ESTIMATES TREND ANALYSIS (2019 – 2026)
7.1. Diagnostic Imaging market share by country, 2016 2024
7.2. China
7.2.1. China Diagnostic Imaging market, 2019 – 2026 (USD billion)
7.3. Japan
7.3.1. Japan Diagnostic Imaging market, 2019 – 2026 (USD billion)
7.4. India
7.4.1. India Diagnostic Imaging market, 2019 – 2026 (USD billion)
7.5. South Korea
7.5.1. South Korea Diagnostic Imaging market, 2019 – 2026 (USD billion)
7.6. Australia
7.6.1. Australia Diagnostic Imaging market, 2019 – 2026 (USD billion)

8. MARKET SHARE ANALYSIS
8.1. Regional Diagnostic Imaging Market Share Analysis, by Key Players
8.1.1. China Diagnostic Imaging Market Share Analysis, by Key Players
8.1.2. Japan Diagnostic Imaging Market Share Analysis, by Key Players
8.1.3. India Diagnostic Imaging Market Share Analysis, by Key Players
8.1.4. South Korea Diagnostic Imaging Market Share Analysis, by Key Players
8.1.5. Australia Diagnostic Imaging Market Share Analysis, by Key Players
8.2. Diagnostic Imaging Market: Key Innovators
8.3. Patent Analysis Year 2017

9. MARKET COMPETITION ANALYSIS
9.1. Strategy Framework
9.2. Company Profiles
9.2.1. Fujifilm Holdings
9.2.1.1. Company overview
9.2.1.2. Key financials
9.2.1.3. Product landscape
9.2.1.4. Strategic initiatives
9.2.1.5. SWOT analysis
9.2.2. Shimadzu Corporation
9.2.2.1. Company overview
9.2.2.2. Key financials
9.2.2.3. Product landscape
9.2.2.4. Strategic initiatives
9.2.2.5. SWOT analysis
9.2.3. Carestream Health
9.2.3.1. Company overview
9.2.3.2. Key financials
9.2.3.3. Product landscape
9.2.3.4. Strategic initiatives
9.2.3.5. SWOT analysis
9.2.4. Toshiba Medical Systems Corporation
9.2.4.1. Company overview
9.2.4.2. Key financials
9.2.4.3. Product landscape
9.2.4.4. Strategic initiatives
9.2.4.5. SWOT analysis
9.2.5. Hitachi Medical Corporation
9.2.5.1. Company overview
9.2.5.2. Key financials
9.2.5.3. Product landscape
9.2.5.4. Strategic initiatives
9.2.5.5. SWOT analysis
9.2.6. Safwan
9.2.6.1. Company overview
9.2.6.2. Key financials
9.2.6.3. Product landscape
9.2.6.4. Strategic initiatives
9.2.6.5. SWOT analysis
9.2.7. SCETI K.K.
9.2.7.1. Company overview
9.2.7.2. Key financials
9.2.7.3. Product landscape
9.2.7.4. Strategic initiatives
9.2.7.5. SWOT analysis
9.2.8. Yasu Medical Imaging Technology Co., Ltd
9.2.8.1. Company overview
9.2.8.2. Key financials
9.2.8.3. Product landscape
9.2.8.4. Strategic initiatives
9.2.8.5. SWOT analysis
9.2.9. GE Healthcare
9.2.9.1. Company overview
9.2.9.2. Key financials
9.2.9.3. Product landscape
9.2.9.4. Strategic initiatives
9.2.9.5. SWOT analysis
9.2.10. Philips Healthcare
9.2.10.1. Company overview
9.2.10.2. Key financials
9.2.10.3. Product landscape
9.2.10.4. Strategic initiatives
9.2.10.5. SWOT analysis
9.2.11. Siemens Healthcare
9.2.11.1. Company overview
9.2.11.2. Key financials
9.2.11.3. Product landscape
9.2.11.4. Strategic initiatives
9.2.11.5. SWOT analysis
9.2.12. Medtech
9.2.12.1. Company overview
9.2.12.2. Key financials
9.2.12.3. Product landscape
9.2.12.4. Strategic initiatives
9.2.12.5. SWOT analysis
9.2.13. TEAC
9.2.13.1. Company overview
9.2.13.2. Key financials
9.2.13.3. Product landscape
9.2.13.4. Strategic initiatives
9.2.13.5. SWOT analysis
9.2.14. Ambra Health
9.2.14.1. Company overview
9.2.14.2. Key financials
9.2.14.3. Product landscape
9.2.14.4. Strategic initiatives
9.2.14.5. SWOT analysis
9.2.15. Bracco Imaging S.p.A.
9.2.15.1. Company overview
9.2.15.2. Key financials
9.2.15.3. Product landscape
9.2.15.4. Strategic initiatives
9.2.15.5. SWOT analysis
9.2.16. Voyager Imaging
9.2.16.1. Company overview
9.2.16.2. Key financials
9.2.16.3. Product landscape
9.2.16.4. Strategic initiatives
9.2.16.5. SWOT analysis
9.2.17. Integral Diagnostics
9.2.17.1. Company overview
9.2.17.2. Key financials
9.2.17.3. Product landscape
9.2.17.4. Strategic initiatives
9.2.17.5. SWOT analysis
9.2.18. Alpenglow Australia
9.2.18.1. Company overview
9.2.18.2. Key financials
9.2.18.3. Product landscape
9.2.18.4. Strategic initiatives
9.2.18.5. SWOT analysis
9.2.19. Barwon Medical Imaging
9.2.19.1. Company overview
9.2.19.2. Key financials
9.2.19.3. Product landscape
9.2.19.4. Strategic initiatives
9.2.19.5. SWOT analysis
9.2.20. Medirays Corporation
9.2.20.1. Company overview
9.2.20.2. Key financials
9.2.20.3. Product landscape
9.2.20.4. Strategic initiatives
9.2.20.5. SWOT analysis
  • INQUIRE BEFORE BUYING